Guardant Health to Participate in Upcoming November Investor Conferences
03 Novembro 2023 - 9:00AM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will participate in the
following investor conferences:
- Jefferies 14th Annual Global Healthcare Conference in London,
UK Presentation on Thursday, November 16 at 9:00 a.m. Greenwich
Mean Time
- Piper Sandler 35th Annual Healthcare Conference in New York, NY
Fireside Chat on Tuesday, November 28 at 9:30 a.m. Eastern
Time
Interested parties may access live and archived webcasts of the
sessions on the “Investors” section of the company website at:
www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping every person live a life free from cancer. Founded in
2012, Guardant is transforming cancer care by providing critical
insights into what drives the disease through its advanced blood
and tissue tests, real-world data and AI analytics. Guardant tests
help improve patient outcomes across all stages of cancer,
including screening to find cancer early, monitoring for recurrence
in early-stage cancer, and helping doctors select the best
treatment for patients with advanced cancer. For more information,
visit guardanthealth.com and follow the company on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231103008804/en/
Investor Contact: investors@guardanthealth.com
Media Contact: Melissa Morasco press@guardanthealth.com
+1 650-647-3711
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024